IPP Bureau
Zydus Wellness launches pilot for ready-to-drink beverage Glucon-D Activors
By IPP Bureau - May 06, 2024
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Tatva Chintan Pharma Chem posts Q4 FY24 PAT at Rs. 9.61 Cr
By IPP Bureau - May 06, 2024
The company has posted net profit of Rs.30.35 crores for the Financial Year ended March 31, 2024
Astec LifeSciences posts Q4FY24 consolidated loss at Rs. 97.39 lakhs
By IPP Bureau - May 04, 2024
The company has reported total income of Rs. 155.79 crores during the period ended March 31, 2024
Dabur India posts Q4 FY24 consolidated PAT at Rs. 349.53 Cr
By IPP Bureau - May 04, 2024
The company has reported total income of Rs. 2,943.49 crores during the period ended March 31, 2024
Wipro to implement Independent Health’s Medicare prescription payment plan platform
By IPP Bureau - May 04, 2024
Wipro's MPPP360 platform will assist Independent Health in streamlining the payment process to seamlessly integrate these new provisions
Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr
By IPP Bureau - May 04, 2024
The company has reported total income of Rs. 1,089.58 crores during the period ended March 31, 2024
Bayer secures full ownership in Bayer Zydus Pharma by acquiring remaining 25% stake
By IPP Bureau - May 03, 2024
The JV successfully leveraged the strengths of both companies to better serve the fast-growing Indian market
RPG Life Sciences posts Q4 FY24 PAT at Rs. 13.24 Cr
By IPP Bureau - May 03, 2024
The company has posted net profit of Rs.87.66 crores for the Financial Year ended March 31, 2024
Novartis to acquire Mariana Oncology for upfront US$ 1 billion
By IPP Bureau - May 03, 2024
Acquisition encompasses a portfolio of RLT programs across a range of solid tumor indications
Moderna posts Q1 2024 revenues at US$167 million
By IPP Bureau - May 03, 2024
GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)
FDA grants full approval for TIVDAK to treat cervical cancer
By IPP Bureau - May 02, 2024
TIVDAK is the first antibody-drug conjugate (ADC) to have positive overall survival data for patients with previously treated recurrent or metastatic cervical cancer
Merck announces positive data for investigational, 21-Valent pneumococcal conjugate vaccine
By IPP Bureau - May 02, 2024
Late-breaker Phase 3 STRIDE-10 trial presented as an oral presentation at European Society of Clinical Microbiology and Infectious Diseases
AstraZeneca unveils latest research across key respiratory and immune-mediated diseases at ATS 2024
By IPP Bureau - May 02, 2024
New data for Tezspire and Breztri demonstrate AstraZeneca’s innovation and commitment to transform care in COPD
Pfizer expects full-year 2024 revenues between US$ 58.5 to US$ 61.5 billion
By IPP Bureau - May 02, 2024
First-quarter 2024 revenues totaled $14.9 billion, a decrease of $3.6 billion, or 20%, compared to the prior-year quarter
Philips Respironics agrees to pay $1.1 billion settlement after CPAP machine recall
By IPP Bureau - May 01, 2024
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
